Tecvayli and Darzalex combination shows unprecedented progression-free survival in relapsed/refractory multiple myeloma, ...
Disc Medicine (IRON) has drawn fresh attention after securing priority FDA review for bitopertin and outlining ...
Advocate Health is the latest local health system to enhance its cancer game with plans for a nearly $100 million, ...
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles ...
The FDA has issued a second complete response letter to Atara Biotherapeutics for its biologicals license application of ...
SOUTH SAN FRANCISCO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene ...
On January 3, 2026, Makati Medical Center switched on the red lights atop its building—an unmistakable signal that the ...
Taiwan-based PharmaEssentia Corporation, a biopharma seeking to deliver new biologics in hematology and oncology, has announced that the US Food and Drug Administration (FDA) has accepted the ...
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine ...
Oscar Lahoud, MD, has been named chief medical officer of NYU Langone Hospital-Brooklyn. Dr. Lahoud shared news of his new role in a Jan. 3 post on LinkedIn. He joined New York City-based NYU Langone ...
Detailed price information for Disc Medicine Inc (IRON-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback